ENANTA PHARMACEUTICALS, INC
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2018 | $20.5M | $414.2M | $63.9M |
| FY2019 | $27.3M | $489.8M | $51.2M |
| FY2020 | $30.6M | $486.1M | $87.1M |
| FY2021 | $39.4M | $438.8M | $57.2M |
| FY2022 | $54.1M | $375.4M | $44.0M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2018 | $20.5M | $414.2M | $63.9M |
| FY2019 | $27.3M | $489.8M | $51.2M |
| FY2020 | $30.6M | $486.1M | $87.1M |
| FY2021 | $39.4M | $438.8M | $57.2M |
| FY2022 | $54.1M | $375.4M | $44.0M |